Status:
UNKNOWN
Molecular Testing of Cancer by Integrated Genomic, Transcriptomic, and Proteomic Analysis
Lead Sponsor:
Rhode Island Hospital
Conditions:
Solid Tumors
Hematological Malignancies
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to discover genetic changes associated with different cancers. With the information from this study the investigators hope to provide better ways to prevent, detect and tr...
Detailed Description
Complex, progressive, multigenic, somatic mutations of the genome are now widely accepted as the primary driving force in the evolution of cancer initiation, growth, metastasis and pharmacoresistance....
Eligibility Criteria
Inclusion
- Documented informed consent
- Patient has either a suspected or confirmed solid tumor or hematological malignancy
- There is enough tissue or body fluid to allow for experimental study
- The patient is over the age of 18
Exclusion
- The patient is unwilling or unable to provide informed consent
Key Trial Info
Start Date :
May 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2015
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT02213822
Start Date
May 1 2013
End Date
August 1 2015
Last Update
August 27 2014
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Rhode Island Comprehensive Cancer Center at East Greenwich
East Greenwich, Rhode Island, United States, 02818
2
Rhode Island Hospital
Providence, Rhode Island, United States, 02903
3
The Miriam Hospital
Providence, Rhode Island, United States, 02906